BACKGROUND: The inflammatory phenotypes of severe asthma in adults may be reflected in peripheral blood. If this were true in children with severe therapy-resistant asthma (STRA), invasive tests could be avoided. At the moment there is no conclusive evidence in children. METHODS: All patients underwent blood tests, exhaled nitric oxide (FeNO), sputum induction, bronchoalveolar lavage (BAL) and endobronchial biopsy (EB). RESULTS: Sixty-three (71.6%) patients had a normal blood profile and only 1/88 had a combined blood eosinophilia and neutrophilia. 76/88 (86%) had normal blood eosinophils, but of these, 84% had airway eosinophilia in either BAL (n = 43;66%) or EB (n = 41;79%). In children with STRA blood eosinophilia was associated with airway eosinophilia. However, normal blood eosinophil levels did not exclude airway eosinophilic inflammation. CONCLUSIONS: Peripheral blood counts are not reliable in characterising airway inflammation in severe asthmatic children exposed to high dose steroid therapy, therefore bronchoscopy with BAL should be considered.
BACKGROUND: The inflammatory phenotypes of severe asthma in adults may be reflected in peripheral blood. If this were true in children with severe therapy-resistant asthma (STRA), invasive tests could be avoided. At the moment there is no conclusive evidence in children. METHODS: All patients underwent blood tests, exhaled nitric oxide (FeNO), sputum induction, bronchoalveolar lavage (BAL) and endobronchial biopsy (EB). RESULTS: Sixty-three (71.6%) patients had a normal blood profile and only 1/88 had a combined blood eosinophilia and neutrophilia. 76/88 (86%) had normal blood eosinophils, but of these, 84% had airway eosinophilia in either BAL (n = 43;66%) or EB (n = 41;79%). In children with STRA blood eosinophilia was associated with airway eosinophilia. However, normal blood eosinophil levels did not exclude airway eosinophilic inflammation. CONCLUSIONS: Peripheral blood counts are not reliable in characterising airway inflammation in severe asthmatic children exposed to high dose steroid therapy, therefore bronchoscopy with BAL should be considered.
Authors: Candace M Crowley; Justin H Fontaine; Joan E Gerriets; Edward S Schelegle; Dallas M Hyde; Lisa A Miller Journal: Toxicol Appl Pharmacol Date: 2017-05-18 Impact factor: 4.219
Authors: W Gerald Teague; Monica G Lawrence; Debbie-Ann T Shirley; Andrea S Garrod; Stephen V Early; Jackie B Payne; Julia A Wisniewski; Peter W Heymann; James J Daniero; John W Steinke; Deborah K Froh; Thomas J Braciale; Michael Ellwood; Drew Harris; Larry Borish Journal: J Allergy Clin Immunol Pract Date: 2019-01-14
Authors: Megan N Januska; David L Goldman; Wilmore Webley; W Gerald Teague; Robyn T Cohen; Supinda Bunyavanich; Alfin G Vicencio Journal: Pediatr Pulmonol Date: 2019-11-15
Authors: Monica G Lawrence; W Gerald Teague; Xin Feng; Caitlin Welch; Elaine Etter; Julie Negri; Marthajoy Spano; Kristin Wavell; Thomas Braciale; John W Steinke; Larry Borish Journal: Ann Allergy Asthma Immunol Date: 2021-08-12 Impact factor: 6.347
Authors: Anne M Fitzpatrick; Susan T Stephenson; Milton R Brown; Khristopher Nguyen; Shaneka Douglas; Lou Ann S Brown Journal: J Allergy Clin Immunol Pract Date: 2016-09-21
Authors: Marzyeh Amini; Dinara Bashirova; Bram P Prins; Eva Corpeleijn; Marcel Bruinenberg; Lude Franke; Pim van der Harst; Gerjan Navis; Bruce H R Wolffenbuttel; Ronald P Stolk; Cisca Wijmenga; Dirkje S Postma; Gerard H Koppelman; H Marike Boezen; Judith Vonk; Harold Snieder; Behrooz Z Alizadeh Journal: PLoS One Date: 2016-12-15 Impact factor: 3.240